Kevin Campbell
Ask VT AI
View News Summary
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a platform for delivering RNA therapeutics to muscle tissue.
- Arsenal extend lead, Villa stun City in tight Premier League clash
- Russia tests nuclear-powered cruise missile, sparking skepticism from experts over its capabilities and risks.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a platform for delivering RNA therapeutics to muscle tissue.
- Arsenal extend lead, Villa stun City in tight Premier League clash
- Russia tests nuclear-powered cruise missile, sparking skepticism from experts over its capabilities and risks.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Kevin Campbell
News from Kevin Campbell
